These four S&P 500 stocks pay 6% and higher dividends, have Buy ratings at top Wall Street firms, and are offering excellent ...

Anheuser-Busch InBev SA/NV (NYSE:BUD – Get Free Report) shares reached a new 52-week low during mid-day trading on Friday . The company traded as low as $48.94 and last traded at $49.02, with a volume ...

Most analysts love Anheuser-Busch InBev, which has an average rating of buy. But there's reason to believe the stock may be overvalued at today's price of $48.85 per share. Let's look at the ...

Anheuser-Busch Inbev SA (BUD) stock saw a decline, ending the day at $48.85 which represents a decrease of $-1.08 or -2.16% from the prior close of $49.93. The stock opened at $49.4 and touched a low ...

In a new advisory, Surgeon General Vivek Murthy recommended that labels on alcoholic beverages be updated to include a ...

Companies like Molson Coors, Anheuser-Busch InBev, and Diageo are investing heavily in zero-proof alternatives, with products ...

Central Pacific Bank Trust Division raised its position in shares of Anheuser-Busch InBev SA/NV (NYSE:BUD – Free Report) by ...

WASHINGTON, DC (Reuters) – Alcoholic drinks should carry a warning about cancer risks on their label, the U.S. Surgeon ...

The US Surgeon General's advisory on cancer and alcohol sent shares of beverage makers lower, but its effects may be much ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

(Reuters) -European shares closed out a holiday-shortened week lower on Friday, with heavyweight luxury firms and spirits ...

With the drinks industry already facing an uncertain outlook heading into the new year, U.S. Surgeon General Vivek Murthy has dealt the business another potential blow, with an advisory this morning ...